Pfizer beats Q1 profit estimates on older drugs demand
RTE
—
Pfizer has today reported first-quarter profit above Wall Street estimates, boosted by sustained demand for older drugs such as blood thinner Eliquis and cancer drug Padcev.
Pfizer beats Q1 earnings estimates
- Pfizer's newer drugs pushed earnings past Wall Street expectations Quartz —
- Pfizer Posts Better-Than-Expected Revenue, Profit Wall Street Journal —
- Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending Wall Street Journal —
- Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth CNBC —
- Earnings Snapshot: Pfizer beats Q1 estimates but misses guidance Seeking Alpha —